Advances in the science and treatment of alcohol use disorder

K Witkiewitz, RZ Litten, L Leggio - Science advances, 2019 - science.org
Alcohol is a major contributor to global disease and a leading cause of preventable death,
causing approximately 88,000 deaths annually in the United States alone. Alcohol use …

Drug addiction: hyperkatifeia/negative reinforcement as a framework for medications development

GF Koob - Pharmacological Reviews, 2021 - ASPET
Compulsive drug seeking that is associated with addiction is hypothesized to follow a
heuristic framework that involves three stages (binge/intoxication, withdrawal/negative affect …

Efficacy of gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: a randomized clinical trial

RF Anton, P Latham, K Voronin, S Book… - JAMA internal …, 2020 - jamanetwork.com
Importance Although an estimated 30 million people meet criteria for alcohol use disorder
(AUD), few receive appropriate pharmacotherapy. A more personalized, symptom-specific …

Effects of alcohol cue reactivity on subsequent treatment outcomes among treatment‐seeking individuals with alcohol use disorder: a multisite randomized, double …

R Miranda Jr, SS O'Malley… - Alcoholism: Clinical …, 2020 - Wiley Online Library
Background The alcohol cue reactivity paradigm is increasingly used to screen medications
for the treatment of alcohol use disorder (AUD) and other substance use disorders. Yet, its …

[HTML][HTML] Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in …

S Khom, L Rodriguez, P Gandhi, D Kirson, M Bajo… - Neurobiology of …, 2022 - Elsevier
Aberrant glucocorticoid signaling via glucocorticoid receptors (GR) plays a critical role in
alcohol use disorder (AUD). Acute alcohol withdrawal and protracted abstinence in …

Safety of gabapentin prescribed for any indication in a large clinical cohort of 571,718 US veterans with and without alcohol use disorder

CT Rentsch, KL Morford, DA Fiellin… - Alcoholism: Clinical …, 2020 - Wiley Online Library
Background Gabapentin is prescribed for seizures and pain and has efficacy for treating
alcohol use disorder (AUD) starting at doses of 900 milligrams per day (mg/d). Recent …

Medication development for alcohol use disorder: a focus on clinical studies

L Leggio, DE Falk, ML Ryan, J Fertig… - Substance Use Disorders …, 2020 - Springer
Compared to other medical disorders, including other brain diseases, the number of
medications approved for alcohol use disorder (AUD) is very small. Disulfiram, naltrexone …

Effects of pharmacologically targeting neuroimmune pathways on alcohol drinking in mice selectively bred to drink to intoxication

AR Ozburn, P Metten, S Potretzke… - Alcoholism: Clinical …, 2020 - Wiley Online Library
Background Rodent models of high alcohol drinking offer opportunities to better understand
factors for alcohol use disorders (AUD) and test potential treatments. Selective breeding was …

Five priority areas for improving medications development for alcohol use disorder and promoting their routine use in clinical practice.

RZ Litten, DE Falk, ML Ryan, J Fertig… - Alcoholism: Clinical and …, 2020 - psycnet.apa.org
The article discusses about the priority areas for improving medications development for
alcohol use disorder and promoting their routine use in clinical practice. During the past 25 …

Gabapentinoids for treatment of alcohol use disorder: a systematic review and meta‐analysis

YC Cheng, YC Huang… - … : Clinical and Experimental, 2020 - Wiley Online Library
Objective Gabapentin (GBP) and pregabalin (PGB) have been used to treat alcohol use
disorder (AUD) and alcohol withdrawal, but with inconsistent results. In this meta‐analysis …